By Amanda Sibley, Head of Safety Services, ProductLife Group
With the overarching goal of improving transparency and accountability, the European Medicines Agency (EMA) has been taking a more comprehensive approach to pharmacovigilance, introducing a set of good pharmacovigilance practice (GVP) guidelines to the European market.
Integral to the GVP guidelines was theintroduction of the pharmacovigilance system master file, or PSMF, which is a detailed description of the pharmacovigilance system used by the marketing authorization holder (MAH) with respect to the holder's authorized medicinal products. The PMSF has been required for new marketing authorization applications since July 2012; it will be optional for existing applications until July 2015. Read more.
ProductLife Group Expands German Operations with Acquisition of Kohne Pharma.
2–3 December 2014, Drug Information Association 15th Conference on European Electronic Document Management (eDM), Berlin
14–16 October 2014, Cosmetic Compliance Summit, London
13–15 October 2014, TOPRA 2014 Annual Symposium, Brussels